ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 2 filers reported holding ALBIREO PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $2,161,000 | +11.6% | 100,000 | 0.0% | 0.46% | +3.1% |
Q3 2022 | $1,936,000 | -2.5% | 100,000 | 0.0% | 0.45% | -14.7% |
Q2 2022 | $1,986,000 | -33.4% | 100,000 | 0.0% | 0.53% | -29.6% |
Q1 2022 | $2,983,000 | +28.1% | 100,000 | 0.0% | 0.75% | +66.2% |
Q4 2021 | $2,329,000 | -25.4% | 100,000 | 0.0% | 0.45% | -7.8% |
Q3 2021 | $3,120,000 | -11.3% | 100,000 | 0.0% | 0.49% | +12.9% |
Q2 2021 | $3,518,000 | -0.2% | 100,000 | 0.0% | 0.43% | -33.2% |
Q1 2021 | $3,525,000 | -6.0% | 100,000 | 0.0% | 0.65% | +72.4% |
Q4 2020 | $3,751,000 | +12.4% | 100,000 | 0.0% | 0.38% | -59.5% |
Q3 2020 | $3,337,000 | – | 100,000 | – | 0.93% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 270,146 | $6,627,000 | 3.42% |
Perceptive Advisors | 1,704,330 | $39,506,000 | 1.50% |
Birchview Capital, LP | 38,000 | $932,000 | 0.88% |
SECTORAL ASSET MANAGEMENT INC | 229,978 | $5,641,000 | 0.77% |
BVF INC/IL | 200,500 | $4,918,000 | 0.64% |
Artal Group S.A. | 500,000 | $12,265,000 | 0.45% |
PA Capital LLC | 14,692 | $360,000 | 0.38% |
Chicago Capital, LLC | 180,911 | $4,438,000 | 0.36% |
TPG Group Holdings (SBS) Advisors, Inc. | 716,381 | $17,573,000 | 0.28% |
Fosun International Ltd | 197,005 | $4,492,000 | 0.27% |